SonoThera

United States · Biotech

Develops ultrasound-mediated nonviral genetic medicines

Funding history

1 round · 1 with disclosed amounts
AnnouncedRoundAmountInvestors
Series B$125MAlexandria Venture Investments — Role not disclosedARCH Venture Partners — Role not disclosedARK Invest — Role not disclosedCureDuchenne Ventures — Role not disclosedDuquesne Family Office — Role not disclosedIllumina Ventures — Role not disclosedJohnson & Johnson Innovation – JJDC — Role not disclosedLeaps by Bayer — Role not disclosedMedical Excellence Capital — Role not disclosedOtsuka Pharmaceutical — Role not disclosedRA Capital — Role not disclosedSymBiosis — Role not disclosedUCB Ventures SA — Role not disclosedVertex Ventures HC — Role not disclosedVida Ventures — Role not disclosedVivo Capital — Role not disclosed
Sourcessonothera.com ↗